Skip to content

Moderate Sedation for Elective Upper Endoscopy With Balanced Propofol Versus Propofol Alone: a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02174588
Enrollment
22
Registered
2014-06-25
Start date
2013-01-07
Completion date
2015-02-04
Last updated
2017-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EGD Procedure

Keywords

sedation, propofol, midazolam

Brief summary

Since introduction in 1989, propofol has gained wide acceptance for sedation during endoscopic procedures. The optimal sedation drug during esophagogastroendoscopy (EGD) is not established. Midazolam and propofol are used for sedation drug. Balanced propofol sedation (BPS) refers to the administration of an opiate, a benzodiazepine, and propofol. In this study, the investigators want to compare the patient satisfaction with EGD following balanced propofol sedation (BPS) versus propofol sedation alone.

Interventions

DRUGMidazolam + propofol

Midazolam and propofol are used for sedation drug. Balanced propofol sedation (BPS) refers to the administration of an opiate, a benzodiazepine, and propofol.

DRUGpropofol

propofol are used for sedation drug

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. over 19 years old, male and female 2. patients who have plan to get esophagogastroduodenoscopy (EGD)

Exclusion criteria

1. ASA class III or IV 2. Allergies to propofol, sulfites or eggs 3. patients who had surgery for esophagus, stomach or duodenum 4. inpatients 5. patients who had sleep apnea, gastroparesis or achalasia 6. patients who are taking sedative drugs more than 6 months 7. pregnancy 8. hypotension (systolic pressure less than 90mmHg), bradycardia (pulse rates less than 50 times per minute) or hypoxia (SpO2 less than 90%) 9. psychiatric or neurologic problems (ex. epilepsy or dementia)

Design outcomes

Primary

MeasureTime frameDescription
visual analog scaleWithin the 24 hours after EGDThe patient satisfaction with EGD following balanced propofol sedation (BPS) versus propofol sedation alone

Secondary

MeasureTime frameDescription
complications ratesWithin the 1 hour after EGDThe recovery time after EGD following balanced propofol sedation versus propofol sedation alone. The safety after EGD following balanced propofol sedation versus propofol sedation alone

Other

MeasureTime frameDescription
complications ratesWithin the 1 hour after EGDThe safety after EGD following balanced propofol sedation versus propofol sedation alone
total dose of the sedation drugsWithin the 1 hour after EGDThe economy after EGD following balanced propofol sedation versus propofol sedation alone
visual analog scaleWithin the 1 hour after EGDThe endoscopist's satisfaction with EGD following balanced propofol sedation (BPS) versus propofol sedation alone

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026